News

  • Home
  • News
  • Updated event details for The 21st Planova™ Workshop

News

Workshops / Seminars

Updated event details for The 21st Planova™ Workshop

We are excited to host the upcoming 21st Planova™ Workshop in San Francisco on October 11 and 12, 2018!

This year's theme is achieving successful virus filtration of challenging molecules. Our speakers are preparing presentations to share their experiences in virus filtration of molecules, including ones with challenging molecule properties, process conditions or process development considerations, so be sure to check them out!

Chairs, speakers and tentative presentation titles are shown below.

■ Chairs

Rachel Specht, Ph.D.
Technical Development Senior Scientist, Process Virology, Pharma Technical Development
Genentech, a member of Roche Group

Ashley Hesslein, Ph.D.
Associate Director, Isolation & Purification, Biological Development, Pharmaceuticals, Bayer US

Barry D. Gooch, Ph.D.
Associate Director, Pathogen Safety NC, BioScience Research Group, Grifols

■ Speakers and Presentations

Virus Filtration Fundamentals

Update on European Regulations
Johannes Blümel, Ph.D., Head of Virus Safety Section, Department of Virology, Paul-Ehrlich-Institut

A Review of Virus Filter Performance -- Critical Process Parameters and Best Practice
Horst Ruppach, Ph.D., Director, Viral Clearance and Virology, Biologics Testing Solutions, Charles River Laboratories

Overview of Challenging Molecules in Virus filtration: Principles and Applications
Tomoko Hongo-Hirasaki, Ph.D., Senior Scientist of Evaluation and Analysis in Virus Filtration, Bioprocess Division, Asahi Kasei Medical

Establishing a Virus Filter Design Space -- Impact of Process Interruption on Parvovirus Retention
Ashlee Smith, Associate Scientist, BioTherapeutics Development - API; Discovery, Product Development & Supply, Janssen Research & Development

Different Apparent Size of Parvoviruses Determined by Virus Filtration
Thomas Nowak, Ph.D., Senior Manager, Pathogen Safety, CSL Behring GmbH

Direct Visualization of Behavior of Virus and Proteins in Planova™ Membrane Filters Using Advanced Microscope System with Confocal Optics
Takayuki Nishizaka, Ph.D., Professor, Department of Physics, Gakushuin University

Process Development
Case Study: Evaluation of the Effects of Process Pause and Pressure Variation on Planova 20N Virus Filter
Samuel Vollert, Process Development Scientist I, Downstream Process Development, ThermoFisher Scientific

Perspective on Viral Filter Selection and Viral Clearance Assessment from a Biology-First Portfolio (tentative)
Ben Tillotson, Ph.D., Senior Scientist, Drug Substance Technologies, Amgen

Nanofiltration: A Seattle Genetics Perspective (tentative)
Doug MacDonald, Senior Scientist, BioProcess Development, Seattle Genetics

Clarification Impurities Impact Viral Filtration of a Therapeutic Antibody
Ryan Zolyomi, Senior Development Associate, Isolation & Purification, Biological Development, Bayer US

Strategy for Virus Filtration Challenges
Matt Luo, Ph.D., Executive Director and Haikuan Liu, Ph.D., Associate Director, Downstream Process Development, Wuxi Biologics (Shanghai)

Robust Manufacturing & New Trends
Meeting Planova™ and Selecting BioEX for Our Monoclonal Antibody (mAb) Manufacturing Process
Yumiko Masuda, Scientist, Biologics Technology Research Laboratories, Biologics Division, Daiichi Sankyo

Of Future Biotechnology Options, and the Central Role of Nanofiltration
Andreas Wieser DI (FH), Senior Laboratory Associate, Global Pathogen Safety, Shire

(Presentation in preparation)
Speaker from uniQure

Challenges of Implementing Virus Filtration into Continuous Manufacturing
Daniel Strauss, Ph.D., Principal Scientist, Science and Technology, Asahi Kasei Bioprocess America

Virus Filtration in Continuous Processing
Bastian Budde, Ph.D., Senior Expert Process Development, Downstream, Process Development, Bayer AG

Evaluating the Impact on Viral Clearance of Multiple Unplanned Interruptions During Virus Removal Filtration
Kevin K. Okimura, Senior Manager, Outsourced Manufacturing, Portola Pharmaceuticals




We look forward to hosting you in San Francisco, one of the centers of biotechnology. Join us in discovering more about the latest applications and strategies for using Planova filters.


Additional information will be released in upcoming announcements and on The 21st Planova™ Workshop Page.